Quincy Bioscience’s New Animal Division To Focus On Canine Cognitive Health
August 18, 2010
Quincy Bioscience, a biotechnology company in Madison, Wis., reported today that it has launched an animal health division that will initially focus on product development for canine cognitive health. The move is based on Quincy Bioscience’s patented jellyfish protein apoaequorin in human trials, which is protecting brain cells against neuronal degeneration, according to the company.… Continue reading...